Red Cell Reference Laboratory, National Blood Centre, Thai Red Cross Society, Bangkok, Thailand.
Research and Development, Clinical Services and Research, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.
Vox Sang. 2022 Nov;117(11):1327-1331. doi: 10.1111/vox.13358. Epub 2022 Sep 14.
High-frequency antigen En (MNS 28) is expressed on glycophorin A (GPA). En(a-) individuals can form anti-En when exposed to GPA. A Thai patient formed an antibody that reacted against all reagent red blood cells (RBCs). The patient received incompatible blood resulting in a fatal haemolytic transfusion reaction (HTR). This study aimed to characterize the antibody detected in the patient and investigate the cause of HTR.
Blood samples from the patient and three of his family members were investigated. Massively parallel sequencing (MPS) and DNA-microarray were used for genotyping. Standard haemagglutination techniques were used for phenotyping and antibody investigations.
DNA sequencing showed the patient was homozygous for GYPA*M c.295delG (p.Val99Ter) predicting En(a-). Three family members were heterozygous for GYPA c.295delG. MPS and DNA-microarray predicted the patient was N- discordant with the N+ RBC phenotype. The patient's plasma was positive with enzyme/chemical-treated reagent RBCs but failed to react with En(a-) and M M RBCs.
The GYPA c.295delG variant prevented GPA expression on RBCs resulting in En(a-) phenotype. The N+ phenotype result was probably due to the anti-N typing reagent detecting 'N' (MNS30) on GPB. The patient's alloantibody has anti-En specificity.
高频抗原 En(MNS28)表达于糖蛋白 A(GPA)上。当 En(a-)个体接触到 GPA 时,可能会产生抗-En。一名泰国患者产生了一种针对所有试剂红细胞(RBC)的抗体。该患者接受了不相容的血液,导致致命的溶血性输血反应(HTR)。本研究旨在对患者所检测到的抗体进行特征分析,并探讨 HTR 的原因。
对患者及其三名家庭成员的血液样本进行了调查。采用大规模平行测序(MPS)和 DNA 微阵列进行基因分型。采用标准血凝技术进行表型和抗体研究。
DNA 测序显示患者为 GYPA*M c.295delG(p.Val99Ter)纯合子,预测为 En(a-)。三名家庭成员为 GYPA c.295delG 杂合子。MPS 和 DNA 微阵列预测患者与 RBC 表型 N+ 不一致,为 N-。患者的血浆与经酶/化学处理的试剂 RBC 呈阳性反应,但与 En(a-)和 MM RBC 无反应。
GYPA c.295delG 变异导致 RBC 上 GPA 表达缺失,表现为 En(a-)表型。N+表型的结果可能是由于抗-N 定型试剂检测到 GPB 上的 'N'(MNS30)。患者的同种异体抗体具有抗-En 特异性。